Related content

Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain

By ÜÜberall Michael A.   Müüller-Schwefe Gerhard H.H.  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1385-1394

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

By Clark A.J.   Ahmedzai S.H.   Allan L.G.   Camacho F.   Horbay G.L.A.   Richarz U.   Simpson K.  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1419-1428

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer

By Vissers Debby   Stam Wiro   Nolte Thomas   Lenre Malin   Jansen Jeroen  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1037-1045

Informa Healthcare

Access to resources Recommend Favorite

Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 19, Iss. 7, 2015-08 ,pp. : 881-888

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative evaluation of efficacy and safety of etodolac and diclofenac sodium injection in patients with postoperative orthopedic pain

By Pareek Anil   Chandurkar Nitin   Gupta Anil   Desai Yatin   Kumar S. Hiranya   Swamy Amit   Sirsikar Ashish  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2107-2115

Informa Healthcare

Access to resources Recommend Favorite